Shanghai Henlius Biotech's (HKG:2696) shares were included in Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect, effective Monday.
The stock connect programs are a collaboration between the Hong Kong, Shanghai and Shenzhen stock exchanges, enabling international and mainland Chinese investors to trade securities in each other's markets.
The biotech firm said its inclusion in the cross-border trading links would expand its shareholder base and boost the liquidity of its shares, Henlius said in a Monday disclosure.
Shares of Henlius fell over 3% in Monday's afternoon trade.